Allosteric GABAA Receptor Compound Brain Penetration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anti-epileptic drugs, such as dipropofol, take a long time to reach therapeutic concentrations in the brain after intravenous injection, limiting their effectiveness in treating epilepsy.
Innovation Solution
Development of an allosteric enhancing compound or prodrug of GABAA receptors, represented by specific chemical formulas, which undergo a Suzuki coupling reaction to enhance brain penetration and efficacy, involving borate ester-based compounds and para-bromo monophenol compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If traditional anti-epileptic drugs such as dipropofol are used, then they can provide anti-epileptic effect through GABAA receptor modulation, but they enter the brain slowly and take a long time to reach therapeutic concentration
Solution Approach 1:
The patent modifies the chemical structure of dipropofol by replacing isopropyl groups with n-propyl groups at specific positions on the biphenyl ring, changing the molecular parameters (hydrophobicity, steric bulk, metabolic stability) to improve blood-brain barrier penetration speed and reduce the time to reach therapeutic concentration while maintaining GABAA receptor modulation capability
2Productivity
If dipropofol is administered intravenously, then it can be delivered systemically, but it cannot achieve fast therapeutic effect against epilepsy at onset
Solution Approach 1:
The structural modification from isopropyl to n-propyl groups changes the pharmacokinetic parameters of the drug, resulting in faster distribution to the brain and quicker achievement of therapeutic effect, addressing the delayed onset problem of traditional anti-epileptic drugs
Solution Approach 2:
The patent creates a derivative compound that copies the core pharmacophore of dipropofol (the biphenyl-diol structure with GABAA receptor binding capability) while modifying peripheral groups to optimize pharmacokinetic properties, particularly brain penetration speed and onset of action
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new compound achieves higher brain tissue concentrations and faster therapeutic effects compared to dipropofol, with improved efficacy in treating epilepsy by entering the brain more easily through the blood-brain barrier.
Implementation Method 1
subjecting a borate ester-based compound (c) and a para-bromo monophenol compound (d) to a Suzuki coupling reaction to obtain the biphenyldiol compound (1)
Data Source
AI summary
The present disclosure provides an allosteric enhancing compound of GABAA receptors or a prodrug thereof, a method for preparing the same, and use thereof. The compound is represented by formula (1), wherein R1 and R2 are each independently selected from isopropyl or n-propyl; and when R1 is n-propyl, R2 is not isopropyl.